AVR

Anteris Technologies Global Corp.

Anteris Technologies Global Corp. (AVR) is rated C (2.5/5) on Deltasharpe Prism, scored against Healthcare sector peers. Its strongest pillar is Profitability (B-); its weakest is Value (D).

Quantitative Factor Evaluation • Updated

Overall Rating
2.5 / 5.0
C
Value
D
Factor Score 1.5 / 5.0
Growth
B-
Factor Score 3.0 / 5.0
Profitability
B-
Factor Score 3.0 / 5.0
Momentum
C
Factor Score 2.2 / 5.0
Revisions
C+
Factor Score 2.6 / 5.0

Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms

Ratings of B- and above are for members.

Register free to see every rating — your first 2 weeks of Premium are on us.

Register — 2 weeks free

Underlying Financial Metrics

P/E Ratio -4.9
EV / EBITDA -3.0
Rev Growth YoY 21.0%
Gross Margin 75.8%
Price Return 3M -40.5%
Price Return 12M 50.4%
Catalyst Signal 0.00
Market Cap $555.7M
TTM Revenue $2.3M
Price / Sales 238.3
ROE -93.3%

Historical Factor Score Progression

Date Value Growth Profitability Momentum Revisions Overall
2026-11-17 D (1.5) B- (3.0) B- (3.0) C (2.2) C+ (2.6) C (2.5)
2026-11-10 D (1.3) B (3.2) B- (3.1) C+ (2.6) C+ (2.6) C+ (2.6)
2026-11-03 D (1.4) B (3.2) B- (3.0) B- (3.1) C+ (2.7) C+ (2.7)
2026-10-27 D+ (1.5) B (3.2) B- (3.0) B- (2.9) C+ (2.6) C+ (2.6)
2026-10-20 D (1.5) B (3.2) B- (3.0) B- (3.0) C+ (2.6) C+ (2.7)
Page 1 of 4